Delhi Health Scam: Were Government Tenders Fixed? Inside the Alleged ₹700 Crore Procurement Scandal#Delhi Health Scam## Delhi Health Procurement Scam# #₹700 Crore Scam# #Delhi ACB Investigation## Dr Vatsala Agarwal# #Dr Vinod Kumar Ranga# #Delhi Government Scam# #GeM Procurement# #Central Procurement Agency# #Tender Manipulation# #Medical Equipment Scam# #Medicine Procurement Scam# #Anti-Corruption Branch# #Delhi News# #Healthcare Corruption# #Public Procurement India#

 Meta Description

Delhi Health Scam: The alleged ₹700 crore health procurement scam has triggered a major Anti-Corruption Branch investigation. Learn about the arrests, alleged tender manipulation, procurement irregularities, shell companies, and what the probe could mean for Delhi's public healthcare system.

Introduction

The alleged Delhi Health Scam has emerged as one of the most significant corruption investigations involving the capital's public healthcare system in recent years. At the centre of the controversy are allegations that government funds worth nearly ₹700 crore, earmarked for medicines and medical equipment, may have been misused through irregularities in the procurement process. The case has sparked widespread public concern, with many questioning whether government tenders were manipulated to favour selected suppliers at the expense of taxpayers and patients.

The investigation has intensified following the arrest of former Director General of Health Services Dr. Vatsala Agarwal and senior health official Dr. Vinod Kumar Ranga by the Anti-Corruption Branch (ACB). According to investigators, procurement procedures, tender conditions, and financial transactions are being closely examined to determine whether public procurement rules were deliberately bypassed to benefit a select group of vendors. Both officials are presumed innocent unless proven guilty in a court of law.

Investigators are also examining allegations that several hospitals refused to accept large quantities of medical equipment purchased under the procurement programme, raising questions about whether the equipment was genuinely required or whether procurement decisions were influenced by factors other than public need. If these allegations are substantiated, they could point to significant weaknesses in planning, oversight, and accountability within Delhi's healthcare procurement system.

Another major focus of the investigation is the alleged use of shell companies and the role of the Central Procurement Agency (CPA) in awarding contracts. Authorities are also scrutinising purchases made through the Government e-Marketplace (GeM) platform to determine whether established procurement guidelines were followed or whether tender specifications were allegedly tailored to favour specific manufacturers or suppliers.

As the probe continues, investigators are analysing procurement records, tender documents, approval files, and financial transactions to establish whether additional government officials, suppliers, manufacturers, or intermediaries were involved. The outcome of this investigation could have far-reaching implications for public procurement practices, financial accountability, and governance within Delhi's healthcare sector.

In this article, we examine the allegations, the arrests made so far, the procurement process under scrutiny, the questions surrounding the alleged manipulation of tenders, and what the ongoing investigation could mean for the future of transparency and accountability in India's public healthcare system.